Insiders Buying Vintage Wine Estates And 3 Other Stocks Under $1

The Dow Jones closed higher by over 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Beasley Broadcast

• The Trade: Beasley Broadcast Group, Inc. (NASDAQ:BBGI) CEO Caroline Beasley acquired a total of 14,285 shares an average price of $0.73. To acquire these shares, it cost around $10,428.
• What’s Happening: Beasley Broadcast Group posted a loss for the third quarter.
• What Beasley Broadcast Does: Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States.

Vintage Wine Estates

• The Trade: Vintage Wine Estates, Inc. (NASDAQ:VWE) Director Jonathan Sebastiani acquired a total of 11,874 shares at an average price of $0.54. To acquire these shares, it cost around $6,387.
• What’s Happening: Vintage Wine Estates posted a wider-than-expected quarterly loss.
• What Vintage Wine Estates Does: Vintage Wine Estates Inc is a family of wineries and wines whose singular focus is producing the finest quality wines and incredible customer experiences with wineries throughout Napa, Sonoma, California's Central Coast, Oregon, and Washington State.

Check This Out: How To Earn $500 A Month From Guess? Stock Following Q3 Earnings Report

Forte Biosciences

• The Trade: Forte Biosciences, Inc. (NASDAQ:FBRX) Director Paul A Wagner acquired a total of 7,366 shares at an average price of $0.44. The insider spent around $3,220 to buy those shares.
• What’s Happening: Forte Biosciences posted a wider third-quarter loss.
• What Forte Biosciences Does: Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease ("GvHD"), vitiligo and alopecia areata ("AA").

ClearOne

• The Trade: ClearOne, Inc. (NASDAQ:CLRO) 10% owner Edward D Bagley acquired a total of 11,700 shares at an average price of $0.77. The insider spent around $9,008 to buy those shares.
• What’s Happening: ClearOne posted a decline in sales for the third quarter.
• What ClearOne Does: ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication.

Don’t forget to check out our premarket coverage here